LT - Priešvėžinis vaistas, kurio sudėtyje yra alfa, alfa, alfa-trifluortimidinas ir timidinfosforilazės inhibitorius
EN - ANTICANCER DRUG CONTAINING ALPHA, ALPHA, ALPHA-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 31/7072 |
(2006.01) |
|
|
A61K 31/506 |
(2006.01) |
|
|
A61K 31/513 |
(2006.01) |
|
|
A61K 31/7068 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
European patent
(11) |
Number of the document |
1849470 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
06712292.9 |
|
Date of filing the European patent application |
2006-01-25 |
(97) |
Date of publication of the European application |
2007-10-31 |
(45) |
Date of publication and mention of the grant of the patent |
2017-06-21
|
(46) |
Date of publication of the claims translation |
2017-07-25
|
PCT application
(86) |
Number |
PCT/JP2006/301097 |
|
Date |
2006-01-25 |
PCT application publication
(87) |
Number |
WO 2006/080327 |
|
Date |
2006-08-03 |
Priority applications
(30) |
Number |
Date |
Country code |
|
42059 |
2005-01-26
|
US |
|
2005165156 |
2005-06-06
|
JP |
Inventors
(72) |
EMURA, Tomohiro, JP
MITA, Akira, JP
|
Grantee
(73) |
Taiho Pharmaceutical Co., Ltd.,
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444,
JP
|
Attorney or representative
(74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
Title
(54) |
Priešvėžinis vaistas, kurio sudėtyje yra alfa, alfa, alfa-trifluortimidinas ir timidinfosforilazės inhibitorius |
|
ANTICANCER DRUG CONTAINING ALPHA, ALPHA, ALPHA-TRIFLUOROTHYMIDINE AND THYMIDINE PHOSPHORYLASE INHIBITOR |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2024-12-19 |
20 |
347.00
EUR
|